What this instrument is
The National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (August Update) Instrument 2026 is a technical update to the Highly Specialised Drugs Program. The program operates under the National Health Act 1953 and is administered by the Department of Health, Disability and Ageing.
The instrument amends the National Health (Highly Specialised Drugs Program) Special Arrangement 2021, which deals with how certain specialised medicines are supplied and subsidised.
What changed
The source text does not specify exactly which drugs, prices, or clinical criteria were changed in this August update.
Timing
This instrument applied from 31 July 2026 and was in force until it was repealed on 12 October 2026.
Relevance
This content relates to the health subsidy scheme rather than general small business compliance, but is relevant to health providers involved in dispensing or prescribing highly specialised drugs under this program.
Key actions
- If a pharmacy or health practice dispenses highly specialised drugs under this program, the current version of the National Health (Highly Specialised Drugs Program) Special Arrangement 2021 can be checked at legislation.gov.au to confirm which listings apply now.
- This particular instrument has already been repealed as of 12 October 2026, so checking for any later replacement instrument covering the same program is advised.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.